244 related articles for article (PubMed ID: 30803992)
1. Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.
Alvarado LJ; Huntsman HD; Cheng H; Townsley DM; Winkler T; Feng X; Dunbar CE; Young NS; Larochelle A
Blood; 2019 May; 133(19):2043-2055. PubMed ID: 30803992
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells.
Guenther KL; Cheruku PS; Cash A; Smith RH; Alvarado LJ; Burkett S; Townsley DM; Winkler T; Larochelle A
Exp Hematol; 2019 May; 73():1-6.e6. PubMed ID: 30986494
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag.
Kao YR; Chen J; Narayanagari SR; Todorova TI; Aivalioti MM; Ferreira M; Ramos PM; Pallaud C; Mantzaris I; Shastri A; Bussel JB; Verma A; Steidl U; Will B
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209246
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation.
Subbarayan R; Srinivasan D; Shadula Osmania S; Murugan Girija D; Ikhlas S; Srivastav N; Balakrishnan R; Shrestha R; Chauhan A
Platelets; 2024 Dec; 35(1):2359028. PubMed ID: 38832545
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.
Zuo S; Sun L; Wang Y; Chen B; Wang J; Ge X; Lu Y; Yang N; Shen P
Cell Death Dis; 2021 Feb; 12(2):208. PubMed ID: 33627636
[TBL] [Abstract][Full Text] [Related]
7. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
Erhardt JA; Erickson-Miller CL; Aivado M; Abboud M; Pillarisetti K; Toomey JR
Exp Hematol; 2009 Sep; 37(9):1030-7. PubMed ID: 19631713
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin receptor agonists protect human cardiac myocytes from injury by activation of cell survival pathways.
Baker JE; Su J; Koprowski S; Dhanasekaran A; Aufderheide TP; Gross GJ
J Pharmacol Exp Ther; 2015 Mar; 352(3):429-37. PubMed ID: 25512369
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ impairs proliferation of hematopoietic stem cells in mice.
de Bruin AM; Demirel Ö; Hooibrink B; Brandts CH; Nolte MA
Blood; 2013 May; 121(18):3578-85. PubMed ID: 23487025
[TBL] [Abstract][Full Text] [Related]
11. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Erickson-Miller CL; Delorme E; Tian SS; Hopson CB; Landis AJ; Valoret EI; Sellers TS; Rosen J; Miller SG; Luengo JI; Duffy KJ; Jenkins JM
Stem Cells; 2009 Feb; 27(2):424-30. PubMed ID: 19038790
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.
Lee S; Zhan H
Stem Cell Reports; 2024 Feb; 19(2):211-223. PubMed ID: 38215758
[TBL] [Abstract][Full Text] [Related]
13. Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.
Di Buduo CA; Currao M; Pecci A; Kaplan DL; Balduini CL; Balduini A
Haematologica; 2016 Dec; 101(12):1479-1488. PubMed ID: 27515246
[TBL] [Abstract][Full Text] [Related]
14. A role for thrombopoietin in hemangioblast development.
Perlingeiro RC; Kyba M; Bodie S; Daley GQ
Stem Cells; 2003; 21(3):272-80. PubMed ID: 12743322
[TBL] [Abstract][Full Text] [Related]
15. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag inhibits Type I interferon-mediated antiviral signaling by decreasing cellular iron.
Ma S; Liu A; Hu X; Feng Q; Zhang Y; Li N; Peng J; Sheng Z
Biochem Pharmacol; 2021 Apr; 186():114436. PubMed ID: 33539815
[TBL] [Abstract][Full Text] [Related]
17. Novel pathways to erythropoiesis induced by dimerization of intracellular C-Mpl in human hematopoietic progenitors.
Parekh C; Sahaghian A; Kim W; Scholes J; Ge S; Zhu Y; Asgharzadeh S; Hollis R; Kohn D; Ji L; Malvar J; Wang X; Crooks G
Stem Cells; 2012 Apr; 30(4):697-708. PubMed ID: 22290824
[TBL] [Abstract][Full Text] [Related]
18. Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
Erickson-Miller CL; Pillarisetti K; Kirchner J; Figueroa DJ; Ottesen L; Martin AM; Liu Y; Kamel YM; Messam C
BMC Cancer; 2012 Sep; 12():405. PubMed ID: 22967017
[TBL] [Abstract][Full Text] [Related]
19. Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
Quintino de Oliveira B; Catto LFB; Santana BAA; Tellechea MF; Scheucher PS; Scheinberg P; Calado RT
Br J Haematol; 2021 Apr; 193(2):410-414. PubMed ID: 33216370
[TBL] [Abstract][Full Text] [Related]
20. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Kühne T; Imbach P
Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
